Melike Camgoz

Melike Camgoz

Auto-generated profile, based on publicly available information

Melike Camgoz

Gazi University, Faculty of Dentistry, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Medical Ultrasound
Verified
Journal Article
Open access
PDF file
DEDeniz Erdil
Deniz Erdil
NBNilsun Bagis
Nilsun Bagis
HEHakan Eren
Hakan Eren
MCMelike Camgoz
Melike Camgoz
KOKaan Orhan
Kaan Orhan
Background: Bruxism is defined as recurrent masticatory muscle activity. Although there is not an agreed treatment method for bruxism, the application of botulinum toxin A (BT-A) has become a reliable lately. This study aimed to evaluate the correlation between the changes in masseter muscle thickness and clenching habits in bruxism patients treated with BT-A. Methods: Twenty-five patients, 23 females and 2 males, diagnosed with possible sleep bruxism were included in the study. The Fonseca Anamnestic Index was applied to the patients to determine their clenching habits and depression levels both before the treatment, and 6 months after it. The masseter muscle thickness was measured using ultrasonography before the treatment and 3 months and 6 months after the treatment. All the patients were injected with a total of 50 U of BT-A, 25 U to each masseter. Results: A statistically significant decrease in masseter muscle thickness was observed in the ultrasonography 3 and 6 months after the BT-A treatment. There was a statistically significant decrease in the Fonseca scores, in which the teeth clenching habits of the patients were evaluated 6 months after the treatment. Although there was a decrease in the depression levels of the patients 6 months after the treatment, this difference was not statistically significant. Conclusion: When the results of this study were evaluated, it was seen that the BT-A injections are an effective, safe, and side effect-free method in the treatment of bruxism and masseter hypertrophy.

1 January 2008 in Journal of Dental Education
Verified
Journal Article
Closed access
PDF file
MCMelike Camgoz
Melike Camgoz
CGCem A. Gurgan
Cem A. Gurgan
KKKyoko Kajiwara
Kyoko Kajiwara
MKMakoto Kawamura
Makoto Kawamura

20 April 2021 in Journal of Advanced Oral Research
Verified
Journal Article
Closed access
PDF file
DEDeniz Erdil
Deniz Erdil
NBNilsun BAGIS
Nilsun BAGIS
HEHakan Eren
Hakan Eren
MCMelike Camgoz
Melike Camgoz
KOKaan Orhan
Kaan Orhan
Aim: Bruxism is defined as the involuntary recurrent masticatory muscle activity characterized by gnashing, grinding, clenching of teeth, and/or pushing the mandible. Factors creating its etiology are peripheral (morphological) or central (physiopathological and physiological), and exogenous. Recently, among physiological factors, depression and bruxism were considered to be related. A definitive treatment method does not exist for bruxism; however, botulinum toxin-A (BT-A) application is an up-to-date and effective way of treatment. The present study is aimed to evaluate the levels of depression in bruxism patients treated with BT-A application. Materials and Methods: A total of 25 individuals (23 females and 2 males) who were diagnosed as bruxism patients were included in the study. 25 U of BT-A for each masseter muscle was injected into the patients. Patients were prospectively observed for a possible change in depression levels by using Beck’s Depression Inventory. The inventory was implemented before and six months after the BT-A application. Depression levels before and six months after the injection were compared. A paired t -test was used to compare “before” and “after” treatment values. One-way analysis of variance and post-hoc Tukey tests were used to evaluate the change in Beck’s Depression Inventory scores according to age groups. Results: The mean total score was 7.80 ± 8.10 before the treatment and 7.16 ± 6.52 six months after the treatment. The decrease in the mean score was not statistically significant ( P > .05). Conclusion: In conclusion, despite the decrease in the mean Beck’s Depression Inventory scores, a statistically significant decrease in the depression levels of patients was not observed.

15 March 2023 in Acta Stomatologica Croatica
Verified
Journal Article
Open access
MCMelike Camgoz
Melike Camgoz
NBNilsun BAGIS
Nilsun BAGIS
EUElif Unsal
Elif Unsal
Smokers with periodontitis are therapeutically challenging. Azithromycin (AZM) may be used as an adjunct to periodontal treatment. The aim of this randomized, double-blind, controlled clinical study was to determine the effect of azithromycin in shallow, moderate, and deep pocket depths in smokers when combined with non-surgical periodontal treatment. Forty-nine patients who smoked at least 20 cigarettes per day for more than 5 years were included in the study; however only 40 completed it. The number of teeth, plaque index (PI), gingival index (GI), PPD, CAL, bleeding on probing (BOP) and gingival recession were recorded at baseline and months 1, 3 and 6. The pocket depths (PD) were grouped as shallow, moderate, and deep. Twenty-four patients assigned to the AZM+ (test) group received AZM (500 mg tablets) once a day for 3 days, beginning on the first day of SRP. The decline in the total number of pockets in all groups was statistically significant from baseline to 1st, baseline to 3rd, baseline to 6th; and from 1st to 3rd and 1st to 6th months. There was a statistically significant increase in the number of shallow pockets between baseline and 3rd, baseline and 6th; and 1st and 6th months (p=0.000) for both groups. Antibiotic administration significantly increased the number of shallow pockets at all time points. However, larger scale controlled clinical studies are needed to verify the efficiency of AZM in smoker periodontitis patients.

1 August 2011 in Journal of Dental Education
Verified
Journal Article
Closed access
PDF file
MCMelike Camgoz
Melike Camgoz
CGCem A. Gurgan
Cem A. Gurgan
MAMurat Akkaya
Murat Akkaya